FDA Moves Blood Test Device Into Class II
Published Date: 6/1/2026
Rule
Summary
The FDA is officially putting the von Willebrand factor assay into Class II, meaning it now has special safety rules but fewer red tape hurdles. This change helps labs and patients get access to this important blood test faster and safer, starting June 1, 2026. If you make or use these devices, expect smoother approvals and no big cost jumps.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Easier Approval Path for Test Makers
The FDA officially classified the von Willebrand factor assay as Class II with special controls effective June 1, 2026 (classification applicable September 29, 2022). That classification lets this device serve as a predicate for future devices so sponsors can use the less burdensome 510(k) premarket notification process instead of a De Novo request or premarket approval.
Faster, Safer Patient Access to Test
FDA says classifying the von Willebrand factor assay into Class II will provide a reasonable assurance of safety and effectiveness and will enhance patients' access to beneficial innovation, in part by reducing regulatory burdens; the order is effective June 1, 2026 (classification applicable September 29, 2022). The device is a prescription test intended to aid diagnosis and management of von Willebrand factor disorders.
New Test Makers Must Meet Specific Study and Label Rules
Manufacturers marketing a von Willebrand factor assay must meet special controls that include detailed design verification and validation (analytical performance such as precision, linearity, detection capability, specimen/reagent stability, and hook effect), clinical comparison studies using representative clinical samples conducted at a minimum of three external sites, pediatric validation when applicable, and labeling that identifies known interferents and summarizes performance. The device remains prescription-only and is subject to premarket notification under section 510(k).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10899 — Medical Devices; Dental Devices; Classification of the Intraoral Cooling Device
The FDA is officially putting the intraoral cooling device into class II, meaning it has special safety rules but fewer hurdles than the highest-risk devices. This change helps make sure the device is safe and effective while making it easier for patients to get this cool tech. The new classification is effective June 1, 2026, but it’s been in place since October 14, 2022, so manufacturers can plan ahead without extra costs.
2026-10904 — Medical Devices; Gastroenterology-Urology Devices; Classification of the Orally Ingested Transient Device for Constipation
The FDA is officially putting the new swallowed device for constipation into a safer, easier-to-manage category called Class II. This change helps make sure the device works well and is safe, while also speeding up patient access to this cool innovation by cutting down red tape. The new rules took effect June 1, 2026, and could save companies time and money getting their devices approved.
2026-10907 — Medical Devices; Anesthesiology Devices; Classification of the Real-Time Ultrasound Anatomy Visualization and Labeling Device for Ultrasound Guided Regional Anesthesia
The FDA is officially classifying a new ultrasound device that helps doctors see and label anatomy in real-time during regional anesthesia as a Class II device, meaning it has special safety rules but fewer hurdles than the strictest category. This change makes it easier and faster for patients to get access to this helpful technology without compromising safety. The new classification is effective June 1, 2026, and could save time and money for device makers and hospitals.
2026-10905 — Medical Devices; Anesthesiology Devices; Classification of the Adjunctive Pain Measurement Device for Anesthesiology
The FDA is officially putting the adjunctive pain measurement device for anesthesiology into Class II, meaning it now has special safety rules but fewer hurdles than the strictest category. This change helps make sure the device is safe and effective while making it easier for patients to get new, helpful technology. The new classification is effective June 1, 2026, and could speed up innovation without extra costs for makers.
2026-10894 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Oropharyngeal Electrical Stimulator
The FDA is officially putting the oropharyngeal electrical stimulator into Class II, meaning it has special safety rules but is easier to get to patients. This change helps make sure the device is safe and effective while cutting down on red tape, so more people can benefit from this cool tech. The new rules took effect on June 1, 2026, but the classification has been in place since September 2022.
2026-10908 — Medical Devices; General Hospital and Personal Use Devices; Classification of the Rigid Sterilization Container With Electronic Monitoring
The FDA is officially classifying rigid sterilization containers with electronic monitoring as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change helps hospitals and medical device makers get these safer, smarter containers to patients faster and easier. The new rules took effect June 1, 2026, making it simpler and potentially less costly to bring these devices to market.
Previous / Next Documents
Previous: 2026-10896 — Standard Instrument Approach Procedures, and Takeoff Minimums and Obstacle Departure Procedures; Miscellaneous Amendments
Starting June 1, 2026, the FAA is updating how pilots approach and take off from certain airports to keep flights safe and smooth. These changes include new rules for landing and takeoff paths because of new tech, obstacles, or air traffic needs. Pilots and airports affected should check the updated procedures online—no extra costs, just safer skies!
Next: 2026-10899 — Medical Devices; Dental Devices; Classification of the Intraoral Cooling Device
The FDA is officially putting the intraoral cooling device into class II, meaning it has special safety rules but fewer hurdles than the highest-risk devices. This change helps make sure the device is safe and effective while making it easier for patients to get this cool tech. The new classification is effective June 1, 2026, but it’s been in place since October 14, 2022, so manufacturers can plan ahead without extra costs.